Cannabis use is permitted in the following situations:

• Neuropathic pain refractory to accessible therapies (drug or nondrug)
• Some forms of drug-resistant epilepsy
• Some cancer-reluctant symptoms related to cancer or cancer therapy
• Palliative situations
• Painful spasticity due to multiple sclerosis or other central nervous system disorders.

Cannabis-containing drugs are prescribed for:

• Insufficient relief
• Or poor tolerance of accessible therapies, whether or not they are drugs.

Your consent is required.

Cannabis-based drugs can be prescribed in 2 pharmaceutical forms:

• Spray inhalation (dried flowers)

• Oral (oil, tablet containing THC and CBD)

These 2 pharmaceutical forms contain THC and CBD.

Cannabis for smoking is excluded from the protocol.

If agreement is reached, a prescription is issued for a prescription up to 28 days by the healthcare professionals of the structures selected for this experiment.

Thereafter, the prescription can be issued by the doctor you have chosen, subject to his agreement and prior training.

Once you have this prescription, you will present it:

• Either in the pharmacy of the reference structure where your inclusion took place
• Or in the city pharmacy you have chosen, subject to its agreement and the prior training of several of its pharmacists.

The 1^era Delivery can be carried out by the city pharmacy you have designated.

Renewal of the order must be done at most every 28 days.

These medicines are covered by the Health Insurance.